← Evidence map

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2021

Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma.

Mariona Riudavets et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34292495